Custom Lucite deal toy marking the acquisition of two royalty interest in sales of breast cancer drug Orserdu. (24AKL125)
Custom Lucite deal toy marking the acquisition of two royalty interest in sales of breast cancer drug Orserdu. (24AKL125)
Crystal commemorative celebrating FDA approval of Ogsiveo, a treatment for desmoid tumors. (24aZH051)
Code name-themed crystal financial tombstone commemorating a partnership between Bayer and Pairwise. The joint venture will center on gene-editing capabilities for five crops: corn, soybean, wheat, cotton, and canola. (23AJH084)
Crystal deal toy marking a debt facility provided for Ocular Therapeutix. The biopharpharmaceutical commpany specializes in the treatment of diseases of the eye, using bioresorbable hydrogel-based technology. (23AJH088)
Crystal financial tombstone commemorating a follow-on offering of stock by Intelligent Bio Solutions. The New York-based life sciences company develops non-invasive monitoring and diagnostic tests. (23AKL447)
Crystal financial tombstone commemorating a public offering of common stock by Kiora Pharmaceuticals. The California-based biotech company concentrates on developing and commercializing treatments for rare retinal diseases. (23AJH059)
Crystal tombstone celebrating a favorable verdict in an antitrust action against Gilead Sciences. The claim had centered on an earlier patent settlement involving Gilead and Teva. (23AKL380)
Lucite deal tombstone commemorating two related royatly transactions. Both deals involve the diabetes drug TZIELD. (23AKL274)
Lucite commemorative marking the first patient dosed in a clinical study involving LunAIRo. Developed by Apnimed, the drug is intended for the treatment of obstructive sleep apnea. (23AZH173)
